Clinical trial
Intestinal Microbiome Post-Azythromycin/Albendazole Treatment
NCT03032042 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intestinal Microbiome Post-Azythromycin/Albendazole Treatment
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- January 31, 2017
- Completion date
- February 28, 2018
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
helminth infection